# NMC Health plc  Positively Revised Guidance and Capital Markets Day

- Link: https://www.directorstalkinterviews.com/nmc-health-plc-positively-revised-guidance-and-capital-markets-day/412760264
- Published: 2018-10-22T07:26:43+01:00
- Author: Charlotte Edwards

**NMC Health plc** (LON: NMC), the leading private healthcare operator in the Gulf
Cooperation Council (GCC) with international services across 17 countries, today
announced that the Company will be holding a Capital Markets Day today at the London
Stock Exchange.

Prashanth Shenoy, Chief Financial Officer of NMC Health, will provide an update 
on guidance given in January, following positive developments in the second half
of 2018. As a result, we now anticipate an increase of 2% in revenue growth from
22% to 24% and an increased EBITDA guidance from $465m to $480m by year-end 2018.

2019 guidance will also point towards continuation of strong organic growth on the
back of sustained ramp-up at key facilities, integration and expansion of acquired
entities as well as strong operational performance. Revenues are forecast to increase
by 22-24% and EBITDA is expected to increase by 18-20%. 2019 guidance does not include
the effects of implementation of IFRS 16. The guidance also does not reflect the
impact of anticipated financial consolidation of National Medical Care Company. 
An update in this regard will be provided once the joint-venture with Hassana/GOSI
has been formalized, which is on track for completion during Q4 18.

During the year 2019, management also anticipates: 1) opening of new greenfield 
facilities, particularly in UAE, 2) continued ramp-up of various facilities across
multiple geographies and 3) full-year consolidation of Aspen Healthcare, all of 
which will impact EBITDA margin.

Management remains confident on the longer-term margin guidance for the Company 
and NMC Health remains on track to achieve 25% EBITDA margin by 2020/2021.

Share on:
